Founded by a team of pathologists and industry executives, PathCentral is executing upon a compelling IT-enabled pathology services business model. The PathCentral solution combines a web-based enterprise software platform with…

General Motors Company ("GM" or the "Company") (NYSE:GM, TSX:GMM) recently announced the pricing of its initial public offering of 549,700,000 shares of Common Stock at $33.00 per share, generating gross…

Gypsii is a publicly traded company offering Location-based, social networking application for use with mobile devices to over 1 million users. M.M Dillon & Co. (“Dillon”) served as Gypsii’s sole…

MM Dillon acted as a placement agent for ContraFect Corporation in connection with its private placement of 4.73 million shares of common stock and warrants to purchase an additional 2.36…

MM Dillon acted as a financial advisor to Valeritas Holdings, Inc. (NASDAQ:VLRX) in its underwritten public offering of 13,700,000 shares of its common stock at a public offering price of…

MM Dillon acted as placement agent for Vermillion Inc. in raising $5.6 million in equity financing through a private stock placement (PIPE).Vermillion directors, members of the management team and other…

MM Dillon acted a s a placement agent for CareDx, Inc. (NASDAQ:CDNA) in selling approximately 592,000 units in a private placement to be issued by CareDx, for aggregate proceeds in…

Vestagen is a medical technology company that we raised $15M for in a private placement. The company manufactures and sells high performance textiles (hydrophobic bacterial resistant clothing) for physicians, nurses…

Akonni is a molecular diagnostic company. We closed on a $7.5M equity investment in the company by the Chinese diagnostic company Righton Diagnostics. Akonni’s Core product lines include TruTip sample…

MM Dillon acted as sole advisor on Hawaii Biotech’s $10M capital raise. HB is developing vaccines for several infectious diseases. They are leaders in developing vaccines for West Nile virus,…